🇺🇸 FDA
Pipeline program

A Study of LY4057996 in Healthy Participants and Participants with Type 1 and Type 2 Diabetes (YKAA)

J6B-MC-YKAA

Phase 1 other active

Quick answer

A Study of LY4057996 in Healthy Participants and Participants with Type 1 and Type 2 Diabetes (YKAA) for Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2
Phase
Phase 1
Modality
other
Status
active

Clinical trials